AM Apollo Medical Holdings, Inc. Stock: price and directors' dealings · United States · SEC (Form 4)Follow the Apollo Medical Holdings, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Operating in the Healthcare & Pharma sector, Apollo Medical Holdings, Inc. has logged 66 public disclosures. The latest transaction was reported on 24 January 2024 (Attribution). Among the most active insiders: Vong John. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 January 2024
All Executives66 Thresholds0 Prospectus0 Other0
Declarations 66 total
◆ See remarks · Executives · 23 Jan 2024
85,130 shares 0Common Stock SEC:0001104659-24-006279:0
◆ Chief Accounting Officer · Executives · 15 Dec 2023
1,813 shares 0Common Stock SEC:0001104659-23-127452:0
◆ Chief Accounting Officer · Executives · 15 Dec 2023
1,813 shares 0Common Stock SEC:0001104659-23-127452:1
◆ Chief Accounting Officer · Executives · 15 Dec 2023
1,813 shares 0Common Stock SEC:0001104659-23-127452:2
◆ Chief Accounting Officer · Executives · 15 Dec 2023
1,813 shares 0Common Stock SEC:0001104659-23-127452:3
◆ Chief Accounting Officer · Executives · 15 Dec 2023
7,100 shares 0Common Stock SEC:0001104659-23-127452:4
◆ Director · Executives · 15 Dec 2023
6,750 shares 0Common Stock SEC:0001104659-23-126898:0
◆ Director · Executives · 15 Dec 2023
5,750 shares 0Common Stock SEC:0001104659-23-126910:0
◆ Executive Chairman · Executives · 15 Dec 2023
30,000 shares 0Common Stock SEC:0001104659-23-126897:0
◆ Director · Executives · 15 Dec 2023
4,750 shares 0Common Stock SEC:0001104659-23-126896:0
◆ President and Co-CEO · Executives · 15 Dec 2023
30,000 shares 0Common Stock SEC:0001104659-23-126900:0
◆ Director · Executives · 15 Dec 2023
3,650 shares 0Common Stock SEC:0001104659-23-126904:0
◆ Director · Executives · 15 Dec 2023
4,750 shares 0Common Stock SEC:0001104659-23-126906:0
◆ Director · Executives · 15 Dec 2023
3,650 shares 0Common Stock SEC:0001104659-23-127015:0
◇ Director · Executives · 6 Dec 2023
7,500 shares @ US$18.11 26.2% of flow Common Stock SEC:0001104659-23-124694:0
◇ Director · Executives · 6 Dec 2023
7,500 shares @ US$18.11 100.0% of flow Common Stock SEC:0001104659-23-124691:0
● Chief Accounting Officer · Executives · 30 Nov 2023
65 shares @ US$33.23 100.0% of flow Common Stock SEC:0001104659-23-123379:0
3,166,561 shares @ US$31.58 82.8% of flow Common Stock SEC:0001104659-23-119144:0
● Chief Accounting Officer · Executives · 16 May 2023
4,164 shares 0Common Stock SEC:0001104659-23-119141:0
● See Remarks · Executives · 14 Apr 2023
2,494 shares @ US$39.06 100.0% of flow Common Stock SEC:0001104659-23-109615:0
● See Remarks · Executives · 16 May 2023
48,086 shares 0Common Stock SEC:0001104659-23-109616:0
◆ Co-Chief Executive Officer · Executives · 16 May 2023
380,053 shares 0Common Stock SEC:0001250853-23-000034:0
◆ See Remarks · Executives · 16 May 2023
130,732 shares 0Common Stock SEC:0001250853-23-000033:0
● Director · Executives · 14 Mar 2023
270,081 shares @ US$35.32 48.7% of flow Common Stock SEC:0001628280-23-008109:0
◇ Director · Executives · 9 Mar 2023
62,500 shares @ US$10.00 3.2% of flow Common Stock SEC:0001250853-23-000009:0
25 of 66 declarations
Load more (41 remaining) 关于 Apollo Medical Holdings, Inc. Apollo Medical Holdings, Inc. (NASDAQ: AMEH) 是一家在美国纳斯达克市场上市的美国医疗保健公司。该公司围绕综合医疗管理和价值导向型护理建立了其特许经营权,其历史可追溯到 1994 年,通过 Network Medical Management,一个由医生领导的组织,总部位于加利福尼亚州阿尔罕布拉。随着时间的推移,Apollo Medical Holdings 通过合并、收购和战略组合进行扩张,创建了一个更广泛的平台,用于护理协调、提供者赋能和风险承担型医疗保健管理。其公司总部位于美国加利福尼亚州阿尔罕布拉。
该公司的商业模式以管理服务组织 (MSOs)、附属独立执业协会 (IPAs) 和参与 CMS 创新模式为中心。实际上,ApolloMed 介于患者、医生、医院、健康计划和其他护理提供者之间,帮助协调护理交付、管理利用率、改善临床结果并支持低成本护理途径。其服务范围包括住院医师服务、护理管理、人口健康管理、分析以及旨在支持基于价值的报销安排的技术赋能工作流程。
从竞争角度来看,ApolloMed 在分散但高度受监管的美国管理式医疗生态系统中,被定位为一家以医生为中心、技术驱动的医疗运营商。其差异化在于将临床整合与行政和分析能力相结合,同时建立服务于受保人群的网络,包括 Medicare 和 Medicaid 成员以及商业患者。该公司历来专注于加利福尼亚州,在南加州、中加州和北加州拥有重要的业务足迹,并致力于深化与医疗团体、IPA、医院和支付方的关系。
最近的战略发展突显了 ApolloMed 对平台扩展和护理交付合作的重视。2022 年,该公司收购了 Orma Health,以加强其为提供者解决方案提供的技术和分析堆栈。2023 年,ApolloMed 宣布与 Wider Circle 建立战略合作伙伴关系,以支持加利福尼亚州高需求 Medicaid 成员的增强型护理管理。2024 年,它还宣布与旧金山湾区大都会的 BASS Medical Group 建立长期合作伙伴关系。总的来说,这些举措表明了以地域扩张、更紧密的提供者联盟以及技术进一步整合到护理管理中的增长战略。对于跟踪 SEC Form 4 内部人交易的投资者而言,这种运营背景是相关的,因为该公司的内部人活动发生在一个仍在通过合作、平台投资和网络整合在美国纳斯达克不断发展的业务中。